Exane Derivatives’s HSBC HSBC Stock Holding History

Exane Derivatives’s Portfolio HSBC Stock Details HSBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-55	Closed	-$49K	–	642
2017 Q4	$49K	Hold	55	–	–	0.01%	339
2017 Q3	$36.9K	Sell	55 -492	-90%	-$21.8K	0.01%	329
2017 Q2	$275K	Sell	547 -117	-18%	-$4.54K	0.06%	186
2017 Q1	$78.7K	Buy	+664	New	+$24.9K	0.02%	240
2015 Q1	–	Sell	-23	Closed	-$100	–	540
2014 Q4	$100	Buy	+23	New	+$981	﹤0.01%	504

Other funds holding HSBC

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Exane Derivatives's HSBC Position: Q3 2016 in Review

Exane Derivatives sold out of HSBC (HSBC) in Q3 2016, closing a stake of 4,714 shares — an estimated $131K sold.

Exane Derivatives first reported a position in HSBC in Q4 2014 and held it in 2 quarters. The position peaked at $2.19M in Q4 2014. 304 funds tracked by Wall St. Rank hold HSBC as of Q3 2016.

Exane Derivatives reported no remaining HSBC position as of Q3 2016 after selling out during the quarter.
Exane Derivatives sold 4,714 HSBC shares in Q3 2016, an estimated $131K.
Exane Derivatives first reported a position in HSBC in Q4 2014 and held it in 2 quarters.
Exane Derivatives's HSBC position peaked at $2.19M in Q4 2014.
304 funds tracked by Wall St. Rank held HSBC as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.